Stocks · Health care · Biological Products, (No Diagnostic Substances)

Vir Biotechnology, Inc.

VIR Clue Score34
United States Fiscal year ends December CIK 0001706431 Results filed 4 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Vicki L Sato
24 Feb 2026
Director
Sold after exercise
200
$10.26
$2.05K
Vicki L Sato
24 Feb 2026
Director
Sold after exercise
42,177
$9.75
$411.31K

What was left out

Form 4 filings counted 39
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 32
Sales straight out of an exercise 2
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,082,172
History held since 10 Oct 2019